Antimicrobial resistance: A global view from the 2013 World Healthcare-Associated Infections Forum

Antimicrobial Resistance and Infection Control

Volumn 2, Issue 1, 2013, Pages

  Huttner, Angela ^a   Harbarth, Stephan ^a   Carlet, Jean ^b   Cosgrove, Sara ^c   Goossens, Herman ^d   Holmes, Alison ^e   Jarlier, Vincent ^f   Voss, Andreas ^g   Pittet, Didier ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b SAINT JOSEPH HOSPITAL   (France)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF ANTWERP   (Belgium)

^e IMPERIAL COLLEGE LONDON   (United Kingdom)

^f ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^g RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Animal medicine; Antibiotic stewardship; Antimicrobial conservation; Antimicrobial resistance; Care bundles; Environment; Global health; Hand hygiene; Human medicine; Infection control; Regulations; Surveillance networks; World Healthcare Associated Infections Forum

Indexed keywords

ANTIINFECTIVE AGENT; BACTERIAL VACCINE; CEFIXIME; CEFTRIAXONE; CEPHALOSPORIN; FEPA; METICILLIN; OCTAMETHYL PYROPHOSPHORAMIDE; PENICILLIN DERIVATIVE; QUINOLONE DERIVATIVE; TETRACYCLINE; UNCLASSIFIED DRUG;

ACINETOBACTER; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL CONSERVATION; BACTERIAL TRANSMISSION; CLOSTRIDIUM DIFFICILE INFECTION; ECONOMIC ASPECT; ENTEROBACTERIACAE PRODUCING NEW DELHI METALLO PROTEASE 1; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ENTEROBACTERIACEAE; FOOD AND DRUG ADMINISTRATION; GRAM NEGATIVE BACTERIUM; HEALTH CARE COST; HEALTH CARE ORGANIZATION; HEALTH PROGRAM; HUMAN; KLEBSIELLA PNEUMONIAE CARBAPENEMASE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORBIDITY; MORTALITY; NEISSERIA GONORRHOEAE; NONHUMAN; NOTE; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; PUBLIC-PRIVATE PARTNERSHIP; REIMBURSEMENT; SANITATION; STREPTOCOCCUS PNEUMONIAE; VACCINATION; VANCOMYCIN RESISTANT ENTEROCOCCUS; WORLD HEALTHCARE ASSOCIATED INFECTIONS FORUM;

EID: 84903631541     PISSN: None     EISSN: 20472994     Source Type: Journal    
DOI: 10.1186/2047-2994-2-31     Document Type: Note

References (67)

1. D'Costa VM, King CE, Kalan L, Morar M, Sung WW, Schwarz C, et al. Antibiotic resistance is ancient. Nature 2011, 477(7365):457-461. 10.1038/nature10388, 21881561.
2. Fleming A. Penicillin. Nobel Lecture, December 11, 1945 1945, Available from: http://www.nobelprize.org/nobel_prizes/medicine/laureates/1945/fleming-lecture.pdf.
3. Penders J, Stobberingh EE, Savelkoul PH, Wolffs PF. The human microbiome as a reservoir of antimicrobial resistance. Front Microbiol 2013, 4:87. 3627978, 23616784.
4. USFDA Summary Report on Antimicrobials Sold or Distributed for Use in Food-Producing Animals 2009, Available from: http://www.fda.gov/downloads/ForIndustry/UserFees/AnimalDrugUserFeeActADUFA/UCM231851.pdf, USFDA.
5. Laxminarayan R. Personal communication 2013,
6. Patel G, Bonomo RA. "Stormy waters ahead": global emergence of carbapenemases. Front Microbiol 2013, 4:48. 3596785, 23504089.
7. Barber M, Rozwadowska-Dowzenko M. Infection by penicillin-resistant staphylococci. Lancet 1948, 2(6530):641-644.
8. Johnson AP, Davies J, Guy R, Abernethy J, Sheridan E, Pearson A, et al. Mandatory surveillance of methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia in England: the first 10 years. J Antimicrob Chemother 2012, 67(4):802-809. 10.1093/jac/dkr561, 22223229.
9. Klevens RM, Morrison MA, Nadle J, Petit S, Gershman K, Ray S, et al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 2007, 298(15):1763-1771. 10.1001/jama.298.15.1763, 17940231.
10. Gastmeier PSC, Behnke M, Geffers C. Dramatic increase of vancomycin-resistant Enterococci in Germany with a belt of very high proportions [abstract] 2013, France: 4th Biennial Healthcare-associated infections Forum Annecy.
11. Tseng SH, Lee CM, Lin TY, Chang SC, Chuang YC, Yen MY, et al. Combating antimicrobial resistance: antimicrobial stewardship program in Taiwan. J Microbiol Immunol Infect 2012, 45(2):79-89. 10.1016/j.jmii.2012.03.007, 22483434.
12. Ziakas PD, Thapa R, Rice LB, Mylonakis E. Trends and significance of VRE colonization in the ICU: a meta-analysis of published studies. PloS one 2013, 8(9):e75658. 10.1371/journal.pone.0075658, 3785502, 24086603.
13. Brolund A, Edquist PJ, Makitalo B, Olsson-Liljequist B, Soderblom T, Tegmark Wisell K, et al. Epidemiology of ESBL-producing Escherichia coli in Sweden 2007-2011. Clin Microbiol Infect 2013, doi: 10.1111/1469-0691.12413. [Epub ahead of print].
14. Colpan A, Johnston B, Porter S, Clabots C, Anway R, Thao L, et al. Escherichia coli sequence type 131 (ST131) subclone H30 as an emergent multidrug-resistant pathogen among US veterans. Clin Infect Dis 2013, 57(9):1256-1265. 10.1093/cid/cit503, 23926176.
15. Reuland EA, Kostense P, et al. Carriage of ESBL-producing enterobacteriaceae in the community and risk factors for carriage [abstract] 2013, France: 4th Biennial World Healthcare-associated Infections Forum Annecy.
16. Reuland EA, Overdevest IT, Al Naiemi N, Kalpoe JS, Rijnsburger MC, Raadsen SA, et al. High prevalence of ESBL-producing enterobacteriaceae carriage in Dutch community patients with gastrointestinal complaints. Clin Microbiol Infect 2013, 19(6):542-549. 10.1111/j.1469-0691.2012.03947.x, 22757622.
17. Patel G, Huprikar S, Factor SH, Jenkins SG, Calfee DP. Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies. Infect Contr Hosp Epidemiol 2008, 29(12):1099-1106.
18. Walsh TR, Weeks J, Livermore DM, Toleman MA. Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study. Lancet Infect Dis 2011, 11(5):355-362. 10.1016/S1473-3099(11)70059-7, 21478057.
19. Allegranzi B, Bagheri Nejad S, Combescure C, Graafmans W, Attar H, Donaldson L, et al. Burden of endemic health-care-associated infection in developing countries: systematic review and meta-analysis. Lancet 2011, 377(9761):228-241. 10.1016/S0140-6736(10)61458-4, 21146207.
20. Bagheri Nejad S, Allegranzi B, Syed SB, Ellis B, Pittet D. Health-care-associated infection in Africa: a systematic review. Bull World Health Organ 2011, 89(10):757-765. 10.2471/BLT.11.088179, 3209981, 22084514.
21. Centers for Disease Control and Prevention Update to CDC's Sexually transmitted diseases treatment guidelines, 2010: oral cephalosporins no longer a recommended treatment for gonococcal infections. MMWR Morb Mortal Wkly Rep 2012, 61(31):590-594. Centers for Disease Control and Prevention.
22. Ohnishi M, Golparian D, Shimuta K, Saika T, Hoshina S, Iwasaku K, et al. Is Neisseria gonorrhoeae initiating a future era of untreatable gonorrhea?: detailed characterization of the first strain with high-level resistance to ceftriaxone. Antimicrob Agents Chemother 2011, 55(7):3538-3545. 10.1128/AAC.00325-11, 3122416, 21576437.
23. Unemo M, Golparian D, Nicholas R, Ohnishi M, Gallay A, Sednaoui P. High-level cefixime- and ceftriaxone-resistant Neisseria gonorrhoeae in France: novel penA mosaic allele in a successful international clone causes treatment failure. Antimicrob Agents Chemother 2012, 56(3):1273-1280. 10.1128/AAC.05760-11, 3294892, 22155830.
24. Smith R, Coast J. The true cost of antimicrobial resistance. BMJ 2013, 346:f1493. 10.1136/bmj.f1493, 23479660.
25. Smith R, Coast J. The economic burden of antimicrobial resistance: why it is more serious than current studies suggest [report] 2012, London: London School of Hygiene & Tropical Medicine.
26. Macfarlane J, Holmes W, Macfarlane R, Britten N. Influence of patients' expectations on antibiotic management of acute lower respiratory tract illness in general practice: questionnaire study. BMJ 1997, 315(7117):1211-1214. 10.1136/bmj.315.7117.1211, 2127752, 9393228.
27. Lambert HP. Don't keep taking the tablets?. Lancet 1999, 354(9182):943-945. 10.1016/S0140-6736(99)01139-3, 10489971.
28. Pittet D, Allegranzi B, Boyce J. The world health organization guidelines on hand hygiene in health care and their consensus recommendations. Infect Contr Hosp Epidemiol 2009, 30(7):611-622.
29. Lee AS, Huttner B, Harbarth S. Control of methicillin-resistant Staphylococcus aureus. Infect Dis Clin North Amer 2011, 25(1):155-179.
30. van der Bij AK, Pitout JD. The role of international travel in the worldwide spread of multiresistant Enterobacteriaceae. J Antimicrob Chemother 2012, 67(9):2090-2100. 10.1093/jac/dks214, 22678728.
31. Harbarth S, Samore MH. Antimicrobial resistance determinants and future control. Emerg Infect Dis 2005, 11(6):794-801. 10.3201/eid1106.050167, 3367590, 15963271.
32. European Commission press release IP/05/1687 22/12/2005 2005 Available from: http://europa.eu/rapid/press-release_IP-05-1687_en.htm, European Commission press release.
33. Kessler DA. Antibiotics and the meat we eat New York Times, 27 March 2013. http://www.nytimes.com/2013/03/28/opinion/antibiotics-and-the-meat-we-eat.html.
34. Collignon P, Aarestrup FM, Irwin R, McEwen S. Human deaths and third-generation cephalosporin use in poultry. Europe. Emerg Infect Dis 2013, 19(8):1339-1340.
35. Overdevest I, Willemsen I, Rijnsburger M, Eustace A, Xu L, Hawkey P, et al. Extended-spectrum beta-lactamase genes of Escherichia coli in chicken meat and humans, The Netherlands. Emerg Infect Dis 2011, 17(7):1216-1222. 10.3201/eid1707.110209, 3381403, 21762575.
36. Kluytmans JA K, Overdevest IT, Willemsen I, den Bergh MF K-V, van der Zwaluw K, Heck M, et al. Extended-spectrum beta-lactamase-producing Escherichia coli from retail chicken meat and humans: comparison of strains, plasmids, resistance genes, and virulence factors. Clin Infect Dis 2013, 56(4):478-487. 10.1093/cid/cis929, 23243181.
37. Cosgrove SE. The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs. Clin Infect Dis 2006, 42(Suppl 2):S82-S89.
38. Casey JA, Curriero FC, Cosgrove SE, Nachman KE, Schwartz BS. High-density livestock operations, crop field application of manure, and risk of community-associated methicillin-resistant staphylococcus aureus infection in Pennsylvania. JAMA Intern Med 2013, epub ahead of print.
39. van Loo I, Huijsdens X, Tiemersma E, de Neeling A, van de Sande-Bruinsma N, Beaujean D, et al. Emergence of methicillin-resistant Staphylococcus aureus of animal origin in humans. Emerg Infect Dis 2007, 13(12):1834-1839. 10.3201/eid1312.070384, 2876750, 18258032.
40. Carlet J, Collignon P, Goldmann D, Goossens H, Gyssens IC, Harbarth S, et al. Society's failure to protect a precious resource: antibiotics. Lancet 2011, 378(9788):369-371. 10.1016/S0140-6736(11)60401-7, 21477855.
41. Jarlier V, Carlet J, McGowan J, Goossens H, Voss A, Harbarth S, et al. Priority actions to fight antibiotic resistance: results of an international meeting. Antimicrob Resis Infect Contr 2012, 1(1):17.
42. Wenzel RP W, Edmond MB. Infection control: the case for horizontal rather than vertical interventional programs. Int J Infect Dis 2010, 14(Suppl 4):S3-S5.
43. Boyce JM. Environmental contamination makes an important contribution to hospital infection. J Hosp Infect 2007, 65(Suppl 2):50-54.
44. Pittet D, Hugonnet S, Harbarth S, Mourouga P, Sauvan V, Touveneau S, et al. Effectiveness of a hospital-wide programme to improve compliance with hand hygiene. Lancet 2000, 356(9238):1307-1312. 10.1016/S0140-6736(00)02814-2, 11073019.
45. Afshari A, Schrenzel J, Ieven M, Harbarth S. Bench-to-bedside review: rapid molecular diagnostics for bloodstream infection - a new frontier?. Crit Care 2012, 16(3):222. 10.1186/cc11202, 3580598, 22647543.
46. Kurupati P, Teh BK, Kumarasinghe G, Poh CL. Identification of vaccine candidate antigens of an ESBL producing Klebsiella pneumoniae clinical strain by immunoproteome analysis. Proteomics 2006, 6(3):836-844. 10.1002/pmic.200500214, 16372264.
47. McConnell MJ, Rumbo C, Bou G, Pachon J. Outer membrane vesicles as an acellular vaccine against Acinetobacter baumannii. Vaccine 2011, 29(34):5705-5710. 10.1016/j.vaccine.2011.06.001, 21679737.
48. Liu Y, Egilmez NK, Russell MW. Enhancement of adaptive immunity to neisseria gonorrhoeae by local intravaginal administration of microencapsulated interleukin 12. J Infect Dis 2013, epub ahead of print.
49. Feachem RG, Hogan RC, Merson MH. Diarrhoeal disease control: reviews of potential interventions. Bull World Health Organ 1983, 61(4):637-640. 2536145, 6354505.
50. MacDougall C, Polk RE. Antimicrobial stewardship programs in health care systems. Clin Microbiol Rev 2005, 18(4):638-656. 10.1128/CMR.18.4.638-656.2005, 1265911, 16223951.
51. Gerber JS, Prasad PA, Fiks AG, Localio AR, Grundmeier RW, Bell LM, et al. Effect of an outpatient antimicrobial stewardship intervention on broad-spectrum antibiotic prescribing by primary care pediatricians: a randomized trial. JAMA 2013, 309(22):2345-2352. 10.1001/jama.2013.6287, 23757082.
52. Nathwani D, Sneddon J, Malcolm W, Wiuff C, Patton A, Hurding S, et al. Scottish antimicrobial prescribing group (SAPG): development and impact of the Scottish national antimicrobial stewardship programme. Int J Antimicrob Agents 2011, 38(1):16-26. 10.1016/j.ijantimicag.2011.02.005, 21515030.
53. Talpaert MJ, Gopal Rao G, Cooper BS, Wade P. Impact of guidelines and enhanced antibiotic stewardship on reducing broad-spectrum antibiotic usage and its effect on incidence of Clostridium difficile infection. J Antimicrob Chemother 2011, 66(9):2168-2174. 10.1093/jac/dkr253, 21676904.
54. Kaki R, Elligsen M, Walker S, Simor A, Palmay L, Daneman N. Impact of antimicrobial stewardship in critical care: a systematic review. J Antimicrob Chemother 2011, 66(6):1223-1230. 10.1093/jac/dkr137, 21460369.
55. Furuya EY, Lowy FD. Antimicrobial-resistant bacteria in the community setting. Nat Rev Microbiol 2006, 4(1):36-45. 10.1038/nrmicro1325, 16357859.
56. National Health Service UK 2013, [cited 20 October 2013]; Available from: http://www.nhs.uk/conditions/Clostridium-difficile/Pages/Introduction.aspx, National Health Service UK.
57. Sabuncu E, David J, Bernede-Bauduin C, Pepin S, Leroy M, Boelle PY, et al. Significant reduction of antibiotic use in the community after a nationwide campaign in France, 2002-2007. PLoS Med 2009, 6(6):e1000084. 10.1371/journal.pmed.1000084, 2683932, 19492093.
58. Bavestrello L, Cabello A, Casanova D. Impact of regulatory measures in the trends of community consumption of antibiotics in Chile. Rev Med Chil 2002, 130(11):1265-1272.
59. Swann M. Report of the joint committee on the use of antibiotics in animal husbandry and veterinary medicine [report] 1969, London, United Kingdom: Her Majesty's Stationery Office.
60. Snitkin ES, Zelazny AM, Thomas PJ, Stock F, Henderson DK, Palmore TN, et al. Tracking a hospital outbreak of carbapenem-resistant Klebsiella pneumoniae with whole-genome sequencing. Sci Transl Med 2012, 4(148):148ra16.
61. Kuhn T. The Structure of Scientific Revolutions 1962, Chicago, IL: University of Chicago Press, 1.
62. Hardin G. The tragedy of the commons. The population problem has no technical solution; it requires a fundamental extension in morality. Science 1968, 162(3859):1243-1248.
63. Gillespie SH. Antibiotic resistance in the absence of selective pressure. I J Antimicrob Agents 2001, 17(3):171-176.
64. Ghafur A, Mathai D, Muruganathan A, Jayalal JA, Kant R, Chaudhary D, et al. The Chennai declaration: a roadmap to tackle the challenge of antimicrobial resistance. Indian J Cancer 2013, 50(1):71-73. 10.4103/0019-509X.104065, 23713050.
65. Chan M. Antimicrobial Resistance in the European Union and the World [speech] 2012,
66. Centers for Disease Control and Prevention Antimicrobial Resistance Threat Report 2013, http://www.cdc.gov/drugresistance/threat-report-2013/, Centers for Disease Control and Prevention.
67. Science Ministers of the G8 G8 Science Ministers Statement 2013, London, UK, https://www.gov.uk/government/publications/g8-science-ministers-statement-london-12-june-2013, Science Ministers of the G8.